In his leadership roles at the NIH and NCI, Varmus has been a strong advocate for increased funding and support for basic and translational cancer research. He has emphasized the importance of scientific rigor and innovation in developing new cancer therapies. His policy work has influenced the allocation of resources towards high-impact research areas, such as cancer immunotherapy and precision oncology.
